The benefits of a prostate cancer screening tool

prostate cancer
Credit: CC0 Public Domain

Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its availability, detection relied on clinical exams and prostate specific antigen screening.

In a study published in BJU International, investigators found that the availability of mpMRIp in Australia since 2012 has correlated with significantly reduced numbers of biopsies by an average of 354.7 per month, with an estimated annual saving of $13.2 million.

"Our research shows publically funded prostate MRI not only represents good policy in terms of health equity, but it also makes sense from a financial perspective," said lead author Thomas Whish-Wilson, BBiomedSc, MD, of St Vincent's Hospital Melbourne and The University of Melbourne, in Australia.


Explore further

MRI feasible for predicting prostate CA in unselected sample

More information: BJU International, DOI: 10.1111/bju.15231
Provided by Wiley
Citation: The benefits of a prostate cancer screening tool (2020, October 7) retrieved 29 October 2020 from https://medicalxpress.com/news/2020-10-benefits-prostate-cancer-screening-tool.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments